ADMA Biologics (ADMA) Prelim. Q4 Revenue Tops Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| ADMA Biologics Inc Com (NASDAQ: ADMA) | Delayed: 10.68 -0.27 (2.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.95 | 52 Week High | $9.65 | |||
| Open | $10.88 | 52 Week Low | $4.15 | |||
| Day High | $10.91 | P/E | N/A | |||
| Day Low | $10.57 | EPS | $-0.01 | |||
| Volume | 1,740,920 | |||||
